Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
23 Jul 2021
2021 Corporate Governance Statement
23 Jul 2021
Annual Report to Shareholders - YE 31 March 2021
23 Jul 2021
Notice of Annual General Meeting/Proxy Form
21 Jul 2021
Results from Successful Phase 1 Clinical Trial of AMP945
29 Jun 2021
Financial Report YE 31 March 2021 - Audited
28 Jun 2021
Amplia and Garvan Enter Into Collaboration Agreement
25 Jun 2021
Annual General Meeting to be Held 27 August 2021
08 Jun 2021
Change of Director's Interest - Dr. Lambert Exercise Options
07 Jun 2021
Application for quotation of securities - ATX
07 Jun 2021
Application for quotation of securities - ATX
Previous
1
2
3
4
5
6
7
8
9
Next
